APOE and Alzheimer disease: The classification of AD from CN was investigated using a combination of fluorodeoxyglucose positron emission tomography, structural MRI, CSF protein levels, and apolipoprotein‐E (ApoE) genotype with an SVM ML method (Gupta et al., 2019).